Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors
- PMID: 1323786
- DOI: 10.1159/000186936
Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors
Abstract
We studied the anti-HCV prevalence in the same period in all the dialysis patients, staff members and blood donors of the same geographical area. In our opinion, the low prevalence (10.26%) in dialysis patients is strictly correlated to the low prevalence (0.46%) in blood donors.
Similar articles
-
Prevalence of hepatitis C virus antibodies in hemodialysis patients in the area of Milan.Nephron. 1992;61(3):271-2. doi: 10.1159/000186902. Nephron. 1992. PMID: 1323769
-
Prevalence of hepatitis C infection in a hemodialysis unit.Nephron. 1992;61(3):326-7. doi: 10.1159/000186925. Nephron. 1992. PMID: 1323782
-
Hepatitis C virus in dialysis units: a multicenter study.Nephron. 1992;61(3):309-10. doi: 10.1159/000186916. Nephron. 1992. PMID: 1323777
-
[Anti-HVC antibodies and raw-material plasma: reflections and strategy].Rev Fr Transfus Hemobiol. 1990 Oct;33(5):351-4. doi: 10.1016/s1140-4639(05)80043-7. Rev Fr Transfus Hemobiol. 1990. PMID: 2177597 Review. French. No abstract available.
-
Hepatitis C virus-induced liver disease in dialysis patients.Nephrol Dial Transplant. 2000;15 Suppl 8:42-5. doi: 10.1093/ndt/15.suppl_8.42. Nephrol Dial Transplant. 2000. PMID: 11261703 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical